Literature DB >> 16617004

Quantitative prognostic indicators of peritoneal dissemination of gastric cancer.

Y Yonemura1, E Bandou, T Kawamura, Y Endou, T Sasaki.   

Abstract

There are three classifications that describe the quantitative prognostic indicators of peritoneal dissemination for gastric cancer. The Japanese classification (P1, P2, and P3, Lyon classification, (stage I, II, stage III, and stage IV), and the Peritoneal Cancer Index (PCI). Carcinomatosis with limited extent (P1/ P2) corresponds to the PCI less than 13 and the stage I and II from Lyon classification. Carcinomatosis with large extent (P3) corresponds to PCI of 13 or larger and stage III and IV from Lyon classification. PCI enables one to describe the precise distribution of peritoneal dissemination. All three classifications correlate with prognosis. With regard to the surgical cytoreduction of the primary tumor and the peritoneal dissemination, Sugarbaker proposed the classification of completeness of cytoreduction (CCR). Patients with no macroscopic residual tumor had significantly better prognosis than those with residual disease. CCR is a valuable prognostic indicator after cytoreductive surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16617004     DOI: 10.1016/j.ejso.2006.03.003

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  21 in total

1.  A third-generation herpesvirus is effective against gastroesophageal cancer.

Authors:  Joyce Wong; Kaitlyn Kelly; Arjun Mittra; Segundo Jaime Gonzalez; Kyo Young Song; Guy Simpson; Robert Coffin; Yuman Fong
Journal:  J Surg Res       Date:  2010-04-01       Impact factor: 2.192

Review 2.  Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.

Authors:  Hassan-Alaa-Hammed Al-Shammaa; Yan Li; Yutaka Yonemura
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

3.  Treatment outcomes of systemic chemotherapy for peritoneal carcinomatosis arising from gastric cancer with no measurable disease: retrospective analysis from a single center.

Authors:  Sook Hee Hong; Yu Ri Shin; Sang Young Roh; Eun Kyoung Jeon; Kyo Yung Song; Cho Hyun Park; Hae Myung Jeon; Young Seon Hong
Journal:  Gastric Cancer       Date:  2012-08-17       Impact factor: 7.370

4.  Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer.

Authors:  Yutaka Yonemura; Ayman Elnemr; Yoshio Endou; Mitsumasa Hirano; Akiyoshi Mizumoto; Nobuyuki Takao; Masumi Ichinose; Masahiro Miura; Yan Li
Journal:  World J Gastrointest Oncol       Date:  2010-02-15

5.  Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis.

Authors:  Masayoshi Hioki; Naoto Gotohda; Masaru Konishi; Toshio Nakagohri; Shinichiro Takahashi; Taira Kinoshita
Journal:  World J Surg       Date:  2010-03       Impact factor: 3.352

6.  Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study.

Authors:  Peng-Cheng Li; Liang-Dong Chen; Fang Zheng; Yan Li
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-31       Impact factor: 4.553

7.  Inhibition of the peritoneal metastasis of human gastric cancer cells by dextran sulphate in vivo and in vitro.

Authors:  Yuanyi Xu; Yunning Huang; Honghong Wang; Yong Liu
Journal:  Oncol Lett       Date:  2016-02-17       Impact factor: 2.967

8.  Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A multicenter propensity score-matched cohort study.

Authors:  Ziying Lei; Jiahong Wang; Zhi Li; Baozhong Li; Jiali Luo; Xuejun Wang; Jin Wang; Mingchen Ba; Hongsheng Tang; Qingjun He; Quanxing Liao; Xiansheng Yang; Tianpei Guan; Han Liang; Shuzhong Cui
Journal:  Chin J Cancer Res       Date:  2020-12-31       Impact factor: 5.087

9.  Development and Validation of a Combined Model for Preoperative Prediction of Lymph Node Metastasis in Peripheral Lung Adenocarcinoma.

Authors:  Qi Li; Xiao-Qun He; Xiao Fan; Chao-Nan Zhu; Jun-Wei Lv; Tian-You Luo
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

Review 10.  Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Gabriel Glockzin; Hans J Schlitt; Pompiliu Piso
Journal:  World J Surg Oncol       Date:  2009-01-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.